MS, multiple sclerosis, 4397

N. diseases: 95; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3539781
Disease: Progressive cGVHD
Progressive cGVHD
0.020 Biomarker disease BEFREE To evaluate the usability of serum GFAP measurement as a biomarker of progressive disease and disease severity in MS. 30570436 2020
CUI: C3539781
Disease: Progressive cGVHD
Progressive cGVHD
0.020 Biomarker disease BEFREE Most of the current therapies, as well as many of the clinical trials, for multiple sclerosis (MS) target the inflammatory autoimmune processes, but less than 20% of all clinical trials investigate potential therapies for the chronic progressive disease stage of MS. 28105588 2017